Coya Therapeutics, Inc. is a clinical-stage biotechnology company which engages in developing proprietary medicinal products to modulate the function of regulatory T cells. The company was founded by Howard Berman in 2020 and is headquartered in Houston, TX.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
8
Frequently Asked Questions
What is Market Cap of Coya Therapeutics Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Coya Therapeutics Inc market cap is $105.37M.
What is the 52-week high for Coya Therapeutics Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Coya Therapeutics Inc 52 week high is $10.24 as of October 25, 2025.
What is the 52-week low for Coya Therapeutics Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Coya Therapeutics Inc 52 week low is $4.65 as of October 25, 2025.
What is the PE ratio of Coya Therapeutics Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Coya Therapeutics Inc’s P/E ratio is -5.08.
What is the Price-to-Book ratio of Coya Therapeutics Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Coya Therapeutics Inc P/B ratio is 3.7219.
What is the 50-day moving average of Coya Therapeutics Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Coya Therapeutics Inc 50-day moving average is $6.20.
How many employess does Coya Therapeutics Inc has?
